Atlas Venture Life Science Advisors »

Korro Bio shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $101M 1.1M 90.00
2023-12-31 $54M 1.1M 47.93

More positions owned by Atlas Venture Life Science Advisors

Dyne Therapeutics Common Stock (DYN)
Kymera Therapeutics Common Stock (KYMR)
Disc Medicine Common Stock (IRON)
Day One Biopharmaceuticals Common Stock (DAWN)
Third Harmonic Bio Common Stock (THRD)
Korro Bio Common Stock (KRRO)
Aerovate Therapeutics Common Stock (AVTE)
Q32 Bio Common Stock
Generation Bio Common Stock (GBIO)
Vigil Neuroscience Common Stock (VIGL)
Replimune Group Common Stock (REPL)
Ikena Oncology Common Stock (IKNA)
AvroBio Common Stock (AVRO)
Dianthus Therapeutics Common Stock (DNTH)
Xilio Therapeutics Common Stock (XLO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Eventide Asset Management
Citadel Advisors
Cormorant Asset Management
Artal Group
Qiming U.S. Ventures Management
72 Investment Holdings
Vanguard Group
Point72 Asset Management
Monashee Investment Management
Citigroup
Susquehanna International
Jane Street
Bank of America Corporation

View all funds holding Korro Bio